Who is sponsoring NCT05735821?

NCT05735821 is sponsored by HATİCE TETİK METİN.

What drugs are being tested in NCT05735821?

Interventions in NCT05735821: Giving breastfeeding training.

What condition does NCT05735821 study?

NCT05735821 studies Breast Feeding, Separation, Family.

Is NCT05735821 still recruiting?

NCT05735821 is currently status unknown. Last updated 23 February 2023.

Last reviewed 2023-02-23 · How we verify

NCT05735821

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of the Training Given to the Unable to Breastfeed Mothers Staying in the Mother's Hotel

Status unknown NA Last updated 23 February 2023

What this trial tests

NA trial testing Giving breastfeeding training in Breast Feeding in 100 participants. Status unknown.

Timeline

17 June 2022

Primary endpoint
1 April 2023

15 June 2023

Quick facts

Lead sponsor	HATİCE TETİK METİN
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	100
Start date	17 June 2022
Primary completion	1 April 2023
Estimated completion	15 June 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Giving breastfeeding training

Conditions studied

Breast Feeding — all drugs for Breast Feeding →
Separation, Family — all drugs for Separation, Family →

Sponsor

HATİCE TETİK METİN

Who can join

Adults 18 to 45, female only, with Breast Feeding or Separation, Family. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was planned as a randomized controlled study to evaluate the effectiveness of breastfeeding behavior development training using Video and Simulator, given to mothers whose babies are in the neonatal intensive care unit and who are staying in the mother's guesthouse. As soon as the mothers who are separated from their babies and who have breastfeeding barriers come together with their babies and the breastfeeding barrier is lifted, to enable them to start breastfeeding effectively the effectiveness of the training, which will be given by applying 2 different methods based on the IMB (Knowledge, Motivation, Behavioral Skills) model will be evaluated. The aim of the training is to develop breastfeeding behavior in mothers and to ensure a secure attachment between mother and baby. (The research will be conducted in a randomized controlled trial model with a pretest-posttest control group.)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of the effectiveness of video and breastfeeding simulator support to mothers who could not breastfeed their babies in the neonatal intensive care unit: a randomized controlled study.
Tetik Metin H, Yiğit F. · · 2025 · cited 1× · PMID 41029203 · DOI 10.1186/s12884-025-08025-w

Verify or expand the search:

Other recruiting trials for Breast Feeding

Currently open trials in the same condition.

NCT07478341 — Hybrid Breastfeeding Education in Late Pregnancy: Effects on Antenatal Attachment and Breastfeeding · NA · recruiting
NCT07371845 — Effect of Teach-Back Education on Breastfeeding and Bonding in Mothers of Preterm Infants · NA · recruiting
NCT07281339 — Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women · NA · recruiting
NCT06621238 — The Effect of Musıc on Labor Paın, Anxıety and Breastfeedıng Success · NA · recruiting
NCT06691932 — At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05735821 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HATİCE TETİK METİN
Last refreshed: 23 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05735821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing